510 related articles for article (PubMed ID: 19300224)
1. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.
Murali R; Hughes MT; Fitzgerald P; Thompson JF; Scolyer RA
Ann Surg; 2009 Apr; 249(4):641-7. PubMed ID: 19300224
[TBL] [Abstract][Full Text] [Related]
2. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
3. A critical review of melanoma pathology reports for patients referred to the Western Australian Melanoma Advisory Service.
Monshizadeh L; Hanikeri M; Beer TW; Heenan PJ
Pathology; 2012 Aug; 44(5):441-7. PubMed ID: 22772338
[TBL] [Abstract][Full Text] [Related]
4. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility of AJCC staging parameters in primary cutaneous melanoma: an analysis of 4,924 cases.
Niebling MG; Haydu LE; Karim RZ; Thompson JF; Scolyer RA
Ann Surg Oncol; 2013 Nov; 20(12):3969-75. PubMed ID: 23851608
[TBL] [Abstract][Full Text] [Related]
6. Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma.
Busam KJ
Am J Clin Pathol; 2001 May; 115(5):743-6. PubMed ID: 11345839
[TBL] [Abstract][Full Text] [Related]
7. Impact of thorough block sampling in the histologic evaluation of melanomas.
Dyson SW; Bass J; Pomeranz J; Jaworsky C; Sigel J; Somach S
Arch Dermatol; 2005 Jun; 141(6):734-6. PubMed ID: 15967919
[TBL] [Abstract][Full Text] [Related]
8. The advantage of using a synoptic pathology report format for cutaneous melanoma.
Karim RZ; van den Berg KS; Colman MH; McCarthy SW; Thompson JF; Scolyer RA
Histopathology; 2008 Jan; 52(2):130-8. PubMed ID: 18184262
[TBL] [Abstract][Full Text] [Related]
9. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
Eigentler TK; Buettner PG; Leiter U; Garbe C;
J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
[TBL] [Abstract][Full Text] [Related]
10. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
11. [Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].
Eigentler TK; Radny P; Kamin A; Weide B; Caroli UM; Garbe C
J Dtsch Dermatol Ges; 2005 Aug; 3(8):592-8. PubMed ID: 16033477
[TBL] [Abstract][Full Text] [Related]
12. Observer variation in the measurement of Breslow depth and Clark's level in thin cutaneous malignant melanoma.
Colloby PS; West KP; Fletcher A
J Pathol; 1991 Mar; 163(3):245-50. PubMed ID: 2013827
[TBL] [Abstract][Full Text] [Related]
13. Histologic classification of tumor-infiltrating lymphocytes in primary cutaneous malignant melanoma. A study of interobserver agreement.
Busam KJ; Antonescu CR; Marghoob AA; Nehal KS; Sachs DL; Shia J; Berwick M
Am J Clin Pathol; 2001 Jun; 115(6):856-60. PubMed ID: 11392882
[TBL] [Abstract][Full Text] [Related]
14. Pathologic and clinical features influencing outcome of thin cutaneous melanoma: correlation with newly proposed staging system.
Finley JW; Gibbs JF; Rodriguez LM; Letourneau R; Driscoll D; Kraybill W
Am Surg; 2000 Jun; 66(6):527-31; discussion 531-2. PubMed ID: 10888127
[TBL] [Abstract][Full Text] [Related]
15. The role of microsatellites as a prognostic factor in primary malignant melanoma.
Shaikh L; Sagebiel RW; Ferreira CM; Nosrati M; Miller JR; Kashani-Sabet M
Arch Dermatol; 2005 Jun; 141(6):739-42. PubMed ID: 15967920
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic study of recurrent Clark level II melanomas.
Glass LF; Guffey JM; Schroer KR; Reintgen D
Semin Surg Oncol; 1993; 9(3):202-7. PubMed ID: 8516604
[TBL] [Abstract][Full Text] [Related]
17. Discordance of histopathologic parameters in cutaneous melanoma: Clinical implications.
Patrawala S; Maley A; Greskovich C; Stuart L; Parker D; Swerlick R; Stoff B
J Am Acad Dermatol; 2016 Jan; 74(1):75-80. PubMed ID: 26514601
[TBL] [Abstract][Full Text] [Related]
18. Quality of histopathological reporting on melanoma and influence of use of a synoptic template.
Haydu LE; Holt PE; Karim RZ; Madronio CM; Thompson JF; Armstrong BK; Scolyer RA
Histopathology; 2010 May; 56(6):768-74. PubMed ID: 20546342
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology, staging (new system), and prognosis of cutaneous melanoma.
Cho YR; Chiang MP
Clin Plast Surg; 2010 Jan; 37(1):47-53. PubMed ID: 19914457
[TBL] [Abstract][Full Text] [Related]
20. Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium.
Niakosari F; Kahn HJ; Marks A; From L
Arch Dermatol; 2005 Apr; 141(4):440-4. PubMed ID: 15837861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
